0001209191-17-024889.txt : 20170404 0001209191-17-024889.hdr.sgml : 20170404 20170404164338 ACCESSION NUMBER: 0001209191-17-024889 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170331 FILED AS OF DATE: 20170404 DATE AS OF CHANGE: 20170404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Onaitis Matthew CENTRAL INDEX KEY: 0001362822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 17738982 MAIL ADDRESS: STREET 1: C/O SOMAXON PHARMACEUTICALS, INC. STREET 2: 10935 VISTA SORRENTO PARKWAY, SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-31 0 0001610618 Cidara Therapeutics, Inc. CDTX 0001362822 Onaitis Matthew 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 0 1 0 0 Gnrl Counsel, CFO & Secretary Employee Stock Option (right to buy) 7.80 2017-03-31 4 A 0 55000 0.00 A 2027-03-30 Common Stock 55000 55000 D The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2017. /s/ Marc Wilson, Attorney-in-fact 2017-04-04